Subthreshold Cannabidiol Potentiates Levetiracetam in the Kainic Acid Model of Temporal Lobe Epilepsy: A Pilot Study

Refractoriness to antiseizure medications is still a major concern in the pharmacotherapy of epilepsy. For this reason, we decided to evaluate the combination of levetiracetam and cannabidiol, administered at a subthreshold dose, to limit the possible adverse effects of this phytocannabinoid. We adm...

Full description

Bibliographic Details
Published in:	Pharmaceuticals
Main Authors:	Chiara Lucchi, Mattia Marcucci, Kawther Ameen Muhammed Saeed Aledresi, Anna-Maria Costa, Giuseppe Cannazza, Giuseppe Biagini
Format:	Article
Language:	English
Published:	MDPI AG 2024-09-01
Subjects:	cannabidiol epilepsy kainic acid levetiracetam
Online Access:	https://www.mdpi.com/1424-8247/17/9/1187

Similar Items

Relationship between Delta Rhythm, Seizure Occurrence and Allopregnanolone Hippocampal Levels in Epileptic Rats Exposed to the Rebound Effect
by: Anna-Maria Costa, et al.
Published: (2021-02-01)

Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
by: Anna-Maria Costa, et al.
Published: (2022-04-01)

Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model
by: Iván Ignacio-Mejía, et al.
Published: (2023-03-01)

Comparative analysis of brivaracetam and levetiracetam in epilepsy treatment
by: Ming-Yuan Hsu, et al.
Published: (2025-01-01)

EFFECTS OF KAINIC ACID ON GLUTATIONE AND NITRITE IN RAT HIPPOCAMPUS
by: Nadka I. Boyadjieva, et al.
Published: (2011-09-01)

Efficacy of Levetiracetam Monotherapy in Childhood Epilepsy
by: Müjgan ARSLAN, et al.
Published: (2017-04-01)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
by: Opeyemi Samson Osuntokun, et al.
Published: (2021-01-01)

Clonidine and Levetiracetam for Tics Compared
by: J Gordon Millichap
Published: (2009-06-01)

Antiepileptic and anti-neuroinflammatory effects of red ginseng in an intrahippocampal kainic acid model of temporal lobe epilepsy demonstrated by electroencephalography
by: Ju Young Kim, et al.
Published: (2018-12-01)

Establishment and comparison of 2 mouse models of kainic acid induced epilepsy
by: TENG Can, et al.
Published: (2024-04-01)

Restless Legs Syndrome in Patients with Epilepsy Under Levetiracetam Monotherapy
by: Gülnihal Kutlu, et al.
Published: (2018-03-01)

Levetiracetam induced rhabdomyolysis
by: Anthony C. Torres, et al.
Published: (2021-01-01)

Changes in the Expression of c-fos and AQP4 in the Hippocampus and Amygdala Regions of Rats with Kainic Acid-Induced Temporal Lobe Epilepsy and Their Role in the Pathogenesis of Disease
by: Emine Taşkıran, et al.
Published: (2022-06-01)

Neuroprotective effects of pink lotus oil in kainic acid-induced epilepsy
by: Ratchaniporn Kongsui, et al.
Published: (2024-09-01)

Stuttering Priapism Associated with Levetiracetam
by: Mehmet Taylan PEKÖZ, et al.
Published: (2018-08-01)

Neurobehavioral Effects of Levetiracetam in Brain Tumor Related Epilepsy
by: Abigail eBernett, et al.
Published: (2013-07-01)

Evaluation of Hemogram Indices of Children with Epilepsy Receiving Short-Term Levetiracetam Treatment
by: Turgay Çokyaman, et al.
Published: (2022-09-01)

Effect of Cuminum cyminum and Rhus pentaphylla extracts on status epilepticus induced by intrahippocampal injection of kainic acid in rat
by: Khadija Oubella, et al.
Published: (2023-08-01)

Outcome Analysis in Epilepsy Patients Undergoing Switchover from Levetiracetam to Brivaracetam
by: Agna Maria Rejy, et al.
Published: (2025-01-01)

Diurnal burden of spontaneous seizures in early epileptogenesis in the post‐kainic acid rat model of epilepsy
by: Stephanie Mizuno, et al.
Published: (2021-06-01)

Anti-seizures therapeutics in patients with epilepsy: an approach to levetiracetam – review
by: Barbara Rusinowska
Published: (2022-08-01)

Neuroprotective effects of trigonelline in kainic acid-induced epilepsy: Behavioral, biochemical, and functional insights
by: Mohammad Faizan, et al.
Published: (2023-12-01)

Long-term levetiracetam monotherapy for partial epilepsy in adults
by: P. N. Vlasov, et al.
Published: (2014-01-01)

Comparative Effectiveness of 100 mg/kg Levetiracetam Injection in Two Different Epilepsy Models: Temporal Lobe Epilepsy and Genetic Absence Epilepsy
by: Elif Tuğçe Erdeve, et al.
Published: (2025-09-01)

Effect of Rosemary Extract against the Toxicity of Kainic Acid in Rats
by: Elahe Naderali, et al.
Published: (2014-10-01)

Effects of Levetıracetam Treatment on the Autonomic Nervous System Functions in Epilepsy Patients
by: Dilek YILMAZ, et al.
Published: (2020-08-01)

Pericardial Injection of Kainic Acid Induces a Chronic Epileptic State in Larval Zebrafish
by: Lise Heylen, et al.
Published: (2021-10-01)

Levetiracetam Reduced the Basal Excitability of the Dentate Gyrus without Restoring Impaired Synaptic Plasticity in Rats with Temporal Lobe Epilepsy
by: Guillermo González-H, et al.
Published: (2020-09-01)

Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
by: Maria Luiza Giraldes de MANREZA, et al.
Published: (2021-06-01)

Add-on Levetiracetam in Children With Refractory Epilepsy: A Systematic Review
by: Ali Abbaskhanian, et al.
Published: (2016-07-01)

Assessing adverse reactions in people living with epilepsy on levetiracetam
by: Luqman Ogunjimi, et al.
Published: (2025-09-01)

Effects of Levetiracetam on the Serum C-Reactive Protein in Children With Epilepsy: A Meta-Analysis
by: You-Feng Zhou, et al.
Published: (2022-04-01)

Once-Daily Extended-Release Levetiracetam Improves Medication Compliance in Adolescent Epilepsy Patients
by: Seung Yeon Jung, et al.
Published: (2021-04-01)

Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy
by: Emma Dreischmeier, et al.
Published: (2021-01-01)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
by: Sanjeev Kharel, et al.
Published: (2022-11-01)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01)

Kainic Acid and MPP+ Induce Upregulation of GLT-1 in Neuroblastoma and Glia Cells
by: Rabia UYARICI, et al.
Published: (2021-04-01)

Exendin-4 Pretreatment Attenuates Kainic Acid-Induced Hippocampal Neuronal Death
by: Yu-Jeong Ahn, et al.
Published: (2021-09-01)

Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potential
by: Jakob eWolfart, et al.
Published: (2015-06-01)

Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies
by: J Gordon Millichap
Published: (2010-03-01)